Today: 9 June 2026
Dow futures slip as Wall Street heads into the final three trading days of 2025

Dow futures slip as Wall Street heads into the final three trading days of 2025

NEW YORK, December 29, 2025, 08:06 ET

  • U.S. stock index futures edged lower ahead of a holiday-shortened week after record highs last week
  • Big tech and AI-linked names dipped in premarket trade, while some miners fell as gold and silver retreated
  • Investors are watching Fed minutes and jobless claims later this week for clues on the 2026 rate path

U.S. stock index futures slipped on Monday, opening the final holiday-shortened week of the year on a cautious note after the S&P 500 and Dow ended last week at record highs. S&P 500 E-mini futures — contracts that track the index and trade nearly around the clock — were down 0.22%, while Nasdaq 100 E-minis fell 0.40% and Dow E-minis were little changed at 05:40 a.m. ET, according to market data.

The late-December rally has left investors focused on whether the market can hold onto year-end gains in thin holiday trading. With just three sessions left in 2025, small moves can look larger than usual as trading desks run lightly staffed and many institutions close out the year.

A key marker is the so-called “Santa Claus rally,” a seasonal pattern tracked by market watchers. It refers to gains in the last five trading days of the year and the first two sessions of January, according to Stock Trader’s Almanac. Reuters

Wall Street’s main indexes finished flat on Friday, but remained on track for December gains, supported by a rebound in technology shares. Reuters cited an upbeat forecast earlier this month from Micron Technology as one driver of the tech-led push higher.

In premarket trading on Monday, several large-cap tech and AI-linked names eased. Nvidia was down 1.1%, Oracle slipped 1.6%, and Tesla fell 1.4% after hitting a record high last week, Reuters reported.

U.S.-listed precious metals miners also moved lower as gold and silver pulled back after back-to-back record highs last week. Newmont fell 2.1%, Hecla Mining dropped 3.5% and Barrick Mining slid 2%, according to Reuters.

Spot prices also softened, with gold down 1.3% at about $4,494 per troy ounce and silver off 2.3% near $75.40, the Associated Press reported. “Scarcity is no longer theoretical,” Stephen Innes of SPI Asset Management wrote, pointing to supply concerns and shifting China export rules for refined silver that take effect on Jan. 1. AP News

Among single-stock movers, DigitalBridge surged 34% after Bloomberg News reported Japan’s SoftBank was in advanced talks to acquire the digital infrastructure firm, Reuters said.

On the macro calendar, investors will watch minutes from the Federal Reserve’s last meeting and weekly jobless claims later this week, in an otherwise light run of U.S. data. Reuters said recent inflation and employment reports have helped keep expectations alive for further rate cuts in 2026, with investors also anticipating a more dovish Fed — meaning more inclined to cut rates — under a new chair.

The market enters the final stretch of the year with strong gains already on the board. The S&P 500 is up about 17% so far in 2025 and has outperformed Europe’s STOXX 600, Reuters reported, as the AI-driven rally helped U.S. stocks regain leadership after earlier periods of diversification away from Wall Street.

Geopolitics is also on traders’ radar after U.S. President Donald Trump said on Sunday he and Ukrainian President Volodymyr Zelenskiy were getting closer to an agreement to end the war, Reuters reported. Markets have been sensitive to Russia-Ukraine headlines, particularly through energy prices and risk appetite.

Trading is expected to remain subdued into year-end, with many investors away from their desks and U.S. markets closed on Thursday for New Year’s Day. That leaves the next few sessions to decide whether the year-end rally extends into early January — or runs out of steam before the calendar turns.

Stock Market Today

  • Unisys (UIS) Exhibits Strong Momentum Yet Remains Undervalued
    June 9, 2026, 10:47 AM EDT. Unisys (UIS) stock demonstrates fast-paced price momentum, gaining 26.4% over four weeks and 72.3% in 12 weeks, signaling robust investor interest. The stock's beta of 1.84 indicates it is 84% more volatile than the market, and it holds a top Momentum Score of A, suggesting a favorable entry point for investors seeking momentum plays. Analysts have raised earnings estimates, boosting UIS to a Zacks Rank #1 (Strong Buy), reflecting high growth expectations. Importantly, UIS appears undervalued with a Price-to-Sales ratio of 0.15, meaning investors pay just 15 cents per dollar of sales, highlighting it as a bargain amidst its momentum. This combination of strong growth and reasonable valuation positions Unisys as a compelling investment opportunity.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Hubble’s new 3I/ATLAS data show twin jets as rare interstellar comet fades
Previous Story

Hubble’s new 3I/ATLAS data show twin jets as rare interstellar comet fades

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Next Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

Go toTop